id
stringlengths 1
5
| question_id
stringlengths 1
5
| document_id
stringlengths 5
7
| question
stringlengths 55
970
| type
stringclasses 1
value | choices
list | context
stringlengths 0
971
| answer
list |
---|---|---|---|---|---|---|---|
300
|
410
|
2575601
|
Compared to Pentobarbital what was the result of Thiopental on Infection?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
There were no differences between groups with respect to the incidence of infections, Sepsis related Organ-Failure Assessment (SOFA) scores before initiation of treatment,
|
[
"no significant difference"
] |
301
|
244
|
2922723
|
Compared to Usual airway clearance techniques what was the result of High frequency chest wall oscillation on FEV1%?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Patients scored the efficacy of their usual ACT significantly higher than for HFCWO (mean difference 14 mm; p=0.002).
|
[
"no significant difference"
] |
302
|
468
|
3387601
|
Compared to intravenous immunoglobulin (IVIG) what was the result of plasma exchange (PE) on side effects?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Examining the treatment groups separately, the significant negative correlation remained for the PE group (p-value = 0.037) and not for the IVIG group (p-value 0.132)
|
[
"no significant difference"
] |
303
|
214
|
1475568
|
Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Hospitalization or death?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline.
|
[
"no significant difference"
] |
304
|
364
|
3580134
|
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Sputum score improvement?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"significantly increased"
] |
305
|
215
|
1475568
|
Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Daily weight monitoring at the end of treatment?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline.
|
[
"significantly increased"
] |
306
|
382
|
3580134
|
Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Incidence of pneumonia?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"no significant difference"
] |
307
|
317
|
3580134
|
Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on 1-hour post-dose FEV1 improvements?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"significantly increased"
] |
308
|
445
|
1468428
|
Compared to no enema what was the result of 1 litre saline enema on Episiorraphy dehiscence rates?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
We found no significant differences in puerperal or neonatal infection rates (Puerperal infection: 41/190 [22%] with enema v 26/182 [14%] without enema; RR 0.66 CI 95%: 0.43 to 1.03; neonatal infection 38/191 [20%] with enema v 40/179 [22%] without enema; RR 1.12, 95% CI 95% 0.76 to 1.66)
|
[
"no significant difference"
] |
309
|
248
|
2922723
|
Compared to Usual airway clearance techniques what was the result of High frequency chest wall oscillation on Visual analogue scale scores for comfort?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Patients scored the efficacy of their usual ACT significantly higher than for HFCWO (mean difference 14 mm; p=0.002).
|
[
"no significant difference"
] |
310
|
263
|
2691927
|
Compared to Conventional open approach what was the result of Laparoscopic surgery on Surgery duration?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure.
|
[
"significantly increased"
] |
311
|
322
|
3580134
|
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Mean FEV1 at 12 hours on the day of randomization?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"significantly increased"
] |
312
|
478
|
2447617
|
Compared to placebo what was the result of progesterone on Instances of complications and adverse events?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
The percentage of favorable outcome was 58% for the patients who were given progesterone and was 42% in the placebo group (P = 0.048). Forty-one percent of patients who were given progesterone and 57% of the placebo group exhibited an unfavorable outcome (P = 0.048).
|
[
"no significant difference"
] |
313
|
411
|
2575601
|
Compared to Pentobarbital what was the result of Thiopental on Hypotension?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
There were no differences between groups with respect to the incidence of infections, Sepsis related Organ-Failure Assessment (SOFA) scores before initiation of treatment,
|
[
"no significant difference"
] |
314
|
476
|
2447617
|
Compared to placebo what was the result of progesterone on The mortality rate?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
The percentage of favorable outcome was 58% for the patients who were given progesterone and was 42% in the placebo group (P = 0.048). Forty-one percent of patients who were given progesterone and 57% of the placebo group exhibited an unfavorable outcome (P = 0.048).
|
[
"significantly decreased"
] |
315
|
437
|
1201146
|
Compared to vehicle control solution (carrier with no diclofenac) what was the result of topical diclofenac solution (Pennsaid®) on 50% reduction in pain?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
There was a significantly greater improvement in score with topical diclofenac compared to vehicle control (Table 2) for pain on walking (-1.2 vs. -0.8; p = 0.014).
|
[
"significantly increased"
] |
316
|
483
|
2899760
|
Compared to anterior cervical decompression and fusion (ACDF) with Trabecular MetalTM (TM) what was the result of raditional Smith–Robinson (SR) procedure with autograft on Radiological fusion?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
usion rate in the SR group was 92%, and in the TM group 69% (P < 0.05).
|
[
"significantly increased"
] |
317
|
484
|
3108665
|
Compared to No medication was given to the control group what was the result of somatostatin on Postoperative complications?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Initially, 6 of 35 (17%) in the treated group who received somatostatin developed complications, whereas 18 of 32 (56%) in the control group developed complications.
|
[
"significantly decreased"
] |
318
|
421
|
1187893
|
Compared to No exercise what was the result of Exercise on Knee injury and Osteoarthritis Outcome Score?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
In the exercise group, an improvement was seen at 6 weeks in the KOOS subscale quality of life compared to the control group (mean change 4.0 vs. -0.7, p = 0.05). The difference between groups was still persistent at 6 months (p = 0.02).
|
[
"no significant difference"
] |
319
|
399
|
2690844
|
Compared to Midline incision what was the result of Transverse incision on Skin-to-skin time?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30).
|
[
"no significant difference"
] |
320
|
239
|
3090298
|
Compared to Pre-surgery baseline what was the result of Photo-refractive keratectomy (PRK) on Contrast sensitivity at 1 month seen at 12 cpd?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63.
|
[
"significantly decreased"
] |
321
|
379
|
3580134
|
Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Incidence of pneumonia?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"no significant difference"
] |
322
|
247
|
2922723
|
Compared to Usual airway clearance techniques what was the result of High frequency chest wall oscillation on Sputum expectoration between treatments in a 24-hour period?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Patients scored the efficacy of their usual ACT significantly higher than for HFCWO (mean difference 14 mm; p=0.002).
|
[
"no significant difference"
] |
323
|
252
|
1831737
|
Compared to Communities that received standard Government services what was the result of Communities that received additional education and preventive measures on HIV-1 incidence?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful.
|
[
"no significant difference"
] |
324
|
458
|
1913177
|
Compared to prosthetic repair with e-PTFE patch (PR) what was the result of components separation technique (CST) on Postoperative Mortality?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Wound complications were found in 10 of 19 patients after CST and 13 of 18 patients after PR.
|
[
"no significant difference"
] |
325
|
336
|
3580134
|
Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 160/9 μg on Pre-dose inspiratory capacity?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"no significant difference"
] |
326
|
417
|
1784771
|
Compared to Prostaglandin gel what was the result of Prostaglandin gel plus hygroscopic cervical dilators on Changes in Bishop score after 6 hours?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
The combined therapy group had a higher infection rate than the prostaglandin-only group (59% vs. 12%, P = 0.003).
|
[
"significantly increased"
] |
327
|
381
|
3580134
|
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Incidence of pneumonia?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"no significant difference"
] |
328
|
454
|
2720945
|
Compared to placebo what was the result of cineole on Dyspnea during exercise?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
The difference between the two treatment groups was neither clinically relevant nor statistically significant. Safety examinations of the global assessment showed no difference between the two treatment groups.
|
[
"no significant difference"
] |
329
|
414
|
2575601
|
Compared to Pentobarbital what was the result of Thiopental on Intracranial pressure recurrence after treatment withdrawal?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
There were no differences between groups with respect to the incidence of infections, Sepsis related Organ-Failure Assessment (SOFA) scores before initiation of treatment,
|
[
"no significant difference"
] |
330
|
362
|
3580134
|
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Breathlessness Cough and Sputum Scale improvement?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"significantly increased"
] |
331
|
419
|
1784771
|
Compared to Prostaglandin gel what was the result of Prostaglandin gel plus hygroscopic cervical dilators on Induction time?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
The combined therapy group had a higher infection rate than the prostaglandin-only group (59% vs. 12%, P = 0.003).
|
[
"no significant difference"
] |
332
|
439
|
1201146
|
Compared to vehicle control solution (carrier with no diclofenac) what was the result of topical diclofenac solution (Pennsaid®) on Dry skin at the application site?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
There was a significantly greater improvement in score with topical diclofenac compared to vehicle control (Table 2) for pain on walking (-1.2 vs. -0.8; p = 0.014).
|
[
"significantly increased"
] |
333
|
350
|
3580134
|
Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Amount of exacerbations per patient-treatment year?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"significantly decreased"
] |
334
|
274
|
2691927
|
Compared to Conventional open approach what was the result of Laparoscopic surgery on Better scar appearance score as measured by visual analog scale?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure.
|
[
"significantly increased"
] |
335
|
339
|
3580134
|
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on Pre-dose inspiratory capacity?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"no significant difference"
] |
336
|
405
|
2690844
|
Compared to Midline incision what was the result of Transverse incision on Scar length?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30).
|
[
"significantly decreased"
] |
337
|
343
|
3580134
|
Compared to Placebo what was the result of Budesonide/formoterol pMDI 320/9 μg on 1-hour post-dose inspiratory capacity mean improvements from baseline to the average over the randomized treatment period ?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"significantly increased"
] |
338
|
449
|
2720945
|
Compared to placebo what was the result of cineole on change of FVC and VC?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
The difference between the two treatment groups was neither clinically relevant nor statistically significant. Safety examinations of the global assessment showed no difference between the two treatment groups.
|
[
"no significant difference"
] |
339
|
245
|
2922723
|
Compared to Usual airway clearance techniques what was the result of High frequency chest wall oscillation on O2 saturation?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Patients scored the efficacy of their usual ACT significantly higher than for HFCWO (mean difference 14 mm; p=0.002).
|
[
"no significant difference"
] |
340
|
424
|
1187893
|
Compared to No exercise what was the result of Exercise on Baseline characteristics?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
In the exercise group, an improvement was seen at 6 weeks in the KOOS subscale quality of life compared to the control group (mean change 4.0 vs. -0.7, p = 0.05). The difference between groups was still persistent at 6 months (p = 0.02).
|
[
"no significant difference"
] |
341
|
225
|
1475568
|
Compared to Standard information about self-care what was the result of Follow-up and thorough education on self-care on Cardiac-related hospitalization?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline.
|
[
"no significant difference"
] |
342
|
464
|
3387601
|
Compared to intravenous immunoglobulin (IVIG) what was the result of plasma exchange (PE) on Period of mechanical ventilation ?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Examining the treatment groups separately, the significant negative correlation remained for the PE group (p-value = 0.037) and not for the IVIG group (p-value 0.132)
|
[
"significantly decreased"
] |
343
|
354
|
3580134
|
Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Dyspnoea score improvement?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"significantly increased"
] |
344
|
426
|
1187893
|
Compared to No exercise what was the result of Exercise on SF-36 Mental Component Summary scale at 6 months?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
In the exercise group, an improvement was seen at 6 weeks in the KOOS subscale quality of life compared to the control group (mean change 4.0 vs. -0.7, p = 0.05). The difference between groups was still persistent at 6 months (p = 0.02).
|
[
"no significant difference"
] |
345
|
398
|
2690844
|
Compared to Midline incision what was the result of Transverse incision on Surgery duration?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30).
|
[
"no significant difference"
] |
346
|
240
|
3090298
|
Compared to Pre-surgery baseline what was the result of Photo-refractive keratectomy (PRK) on Contrast sensitivity at 6 months seen at 3 cpd?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63.
|
[
"significantly decreased"
] |
347
|
271
|
2691927
|
Compared to Conventional open approach what was the result of Laparoscopic surgery on Ulcer location ?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure.
|
[
"no significant difference"
] |
348
|
229
|
3090298
|
Compared to Thin-flap laser in situ keratomileusis (LASIK) what was the result of Photo-refractive keratectomy (PRK) on Uncorrected distance visual acuity at 6 months?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
There were no significant differences between groups in any HOAs throughout the study (P ≥ 0.101), with all P values at 6 months ≥0.63.
|
[
"no significant difference"
] |
349
|
251
|
2922723
|
Compared to Usual airway clearance techniques what was the result of High frequency chest wall oscillation on Adverse events?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Patients scored the efficacy of their usual ACT significantly higher than for HFCWO (mean difference 14 mm; p=0.002).
|
[
"no significant difference"
] |
350
|
342
|
3580134
|
Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on 1-hour post-dose inspiratory capacity mean improvements from baseline to the average over the randomized treatment period ?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"significantly increased"
] |
351
|
260
|
1831737
|
Compared to Baseline communities that received standard Government services what was the result of Baseline communities that received additional education and preventive measures on HIV/AIDS meeting attendance?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful.
|
[
"significantly increased"
] |
352
|
334
|
3580134
|
Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Baseline-adjusted average 12-hour FEV1 at end of treatment?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"significantly increased"
] |
353
|
438
|
1201146
|
Compared to vehicle control solution (carrier with no diclofenac) what was the result of topical diclofenac solution (Pennsaid®) on good or very good PGA response and OMERACT-OARSI responder?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
There was a significantly greater improvement in score with topical diclofenac compared to vehicle control (Table 2) for pain on walking (-1.2 vs. -0.8; p = 0.014).
|
[
"significantly increased"
] |
354
|
358
|
3580134
|
Compared to Placebo what was the result of Budesonide/formoterol pMDI 160/9 μg on Sleep score improvement?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"significantly increased"
] |
355
|
371
|
3580134
|
Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Sleep score improvement?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"significantly increased"
] |
356
|
409
|
2575601
|
Compared to Pentobarbital what was the result of Thiopental on Intracranial pressure control?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
There were no differences between groups with respect to the incidence of infections, Sepsis related Organ-Failure Assessment (SOFA) scores before initiation of treatment,
|
[
"significantly increased"
] |
357
|
413
|
2575601
|
Compared to Pentobarbital what was the result of Thiopental on Mean barbiturate coma length?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
There were no differences between groups with respect to the incidence of infections, Sepsis related Organ-Failure Assessment (SOFA) scores before initiation of treatment,
|
[
"no significant difference"
] |
358
|
373
|
3580134
|
Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 160/9 μg on Cough score improvement?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"significantly increased"
] |
359
|
471
|
2430614
|
Compared to artemether-lumefantrine (AL) what was the result of Artesunate+amodiaquine (AS+AQ) on parasitological or clinical failure rates by day 14 or day 28 in G6PD deficient children?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
the parasitological and clinical failure rate at day 28 post treatment (PCF28) was lower in the AS+AQ group compared to the AL or AS+CD groups (corrected for re-infections: 6.6% vs 13.8% and 13.8% respectively, p = 0.08; uncorrected: 14.6% vs 27.6% and 28.1% respectively, p = 0.005).
|
[
"no significant difference"
] |
360
|
416
|
2575601
|
Compared to Pentobarbital what was the result of Thiopental on Sepsis related Organ-Failure Assessment (SOFA) maximum score during treatment?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
There were no differences between groups with respect to the incidence of infections, Sepsis related Organ-Failure Assessment (SOFA) scores before initiation of treatment,
|
[
"no significant difference"
] |
361
|
313
|
3580134
|
Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 320/9 μg on Pre-dose FEV1 improvement?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"significantly increased"
] |
362
|
353
|
3580134
|
Compared to Formoterol DPI 9 μg what was the result of Budesonide/formoterol pMDI 160/9 μg on Improvements in St. George's Respiratory Questionnaire overall score?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ≤ 0.004) and with budesonide/formoterol 320/9 μg compared with formoterol (p = 0.026) [figure 6].
|
[
"significantly increased"
] |
363
|
466
|
3387601
|
Compared to intravenous immunoglobulin (IVIG) what was the result of plasma exchange (PE) on could walk unaided within four weeks after PICU discharge?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Examining the treatment groups separately, the significant negative correlation remained for the PE group (p-value = 0.037) and not for the IVIG group (p-value 0.132)
|
[
"no significant difference"
] |
364
|
392
|
2690844
|
Compared to Midline incision what was the result of Transverse incision on Pain on day two after surgery?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30).
|
[
"significantly decreased"
] |
365
|
412
|
2575601
|
Compared to Pentobarbital what was the result of Thiopental on Administration of hyperosmolar treatments?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
There were no differences between groups with respect to the incidence of infections, Sepsis related Organ-Failure Assessment (SOFA) scores before initiation of treatment,
|
[
"no significant difference"
] |
366
|
514
|
2829413
|
Compared to Atorvastatin what was the result of Rosuvastatin on Apolipoprotein-B levels after 6 weeks of treatment?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
After 6 weeks of treatment, greater reductions in total cholesterol (- 35.94 ± 11.38 vs. - 30.07 ± 10.46%, p < 0.001), LDL-C (48.04 ± 14.45 vs. 39.52 ± 14.42%, p < 0.001), non-high-density lipoprotein cholesterol (- 42.93 ± 13.15 vs. - 35.52 ± 11.76%, p < 0.001), and apolipoprotein-B (- 38.7 ± 18.85 vs. - 32.57 ± 17.56%, p = 0.002) levels were observed in the rosuvastatin group as compared to the atorvastatin group.
|
[
"significantly decreased"
] |
367
|
515
|
2829413
|
Compared to Atorvastatin what was the result of Rosuvastatin on Patients attaining the NCEP ATP III goal?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
After 6 weeks of treatment, greater reductions in total cholesterol (- 35.94 ± 11.38 vs. - 30.07 ± 10.46%, p < 0.001), LDL-C (48.04 ± 14.45 vs. 39.52 ± 14.42%, p < 0.001), non-high-density lipoprotein cholesterol (- 42.93 ± 13.15 vs. - 35.52 ± 11.76%, p < 0.001), and apolipoprotein-B (- 38.7 ± 18.85 vs. - 32.57 ± 17.56%, p = 0.002) levels were observed in the rosuvastatin group as compared to the atorvastatin group.
|
[
"significantly increased"
] |
368
|
517
|
1261533
|
Compared to Mefloquine-artesunate what was the result of Artemether-lumefantrine on Adverse events?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
The mean (SD) decrease in haematocrit value at day seven from baseline was greater in the group receiving MAS3 than in the ALN group: 9.3% (SD
|
[
"no significant difference"
] |
369
|
526
|
3349250
|
Compared to Interferon (IFN)-α what was the result of Sunitinib on Quality-adjusted survival times?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
sunitinib had higher quality-adjusted survival times than IFN-α across the entire range of utility
|
[
"significantly increased"
] |
370
|
535
|
3198285
|
Compared to high-fiber moderate-GI diet (HF) (target glycemic index GI ~60) what was the result of low–glycemic index diet (target glycemic index [GI] ~50) on birth weight, birth weight centile, prevalence of macrosomia, insulin treatment, adverse pregnancy outcomes?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
The LGI group achieved a modestly lower GI than the HF group (mean ± SEM 47 ± 1 vs. 53 ± 1; P < 0.001).
|
[
"no significant difference"
] |
371
|
540
|
2722000
|
Compared to received antibiotics only when infection was suspected or established what was the result of received antibiotics treatment after randomization with intravenous cefotaxime 2 gram q 8 hr for 7 days on Total mortality and 30-day mortality?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
The rebleeding rate in the prophylactic group was significantly lower than that in the on-demand group (21/62, 33.9% vs. 36/58, 62.1%, p=0.004).
|
[
"no significant difference"
] |
372
|
541
|
2650992
|
Compared to control group what was the result of fibrin glue group (glue sprayed onto the axillary dissection site) on drainage duration?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
The mean drainage duration was 3.3 days for the fibrin glue group and 3.8 days for the control group (p=0.067).
|
[
"no significant difference"
] |
373
|
422
|
1187893
|
Compared to No exercise what was the result of Exercise on Knee injury and Osteoarthritis Outcome Score quality of life subscale at 6 weeks?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
In the exercise group, an improvement was seen at 6 weeks in the KOOS subscale quality of life compared to the control group (mean change 4.0 vs. -0.7, p = 0.05). The difference between groups was still persistent at 6 months (p = 0.02).
|
[
"no significant difference"
] |
374
|
557
|
4785315
|
Compared to standard maternity care what was the result of additional lay support (in this instance Pregnancy Outreach Workers, POWs) on Antenatal attendances?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
no significant differences were seen in the mean EPDS (mean difference (MD) −0.59 (95% CI −1.24 to 0.06)) for all the women recruited
|
[
"no significant difference"
] |
375
|
558
|
4785315
|
Compared to standard maternity care what was the result of additional lay support (in this instance Pregnancy Outreach Workers, POWs) on Mother-to-infant bonding?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
no significant differences were seen in the mean EPDS (mean difference (MD) −0.59 (95% CI −1.24 to 0.06)) for all the women recruited
|
[
"significantly increased"
] |
376
|
568
|
5256321
|
Compared to Biodex Balance System (Biodex Medical Systems, Shirley, NY, USA) what was the result of Spine Balance 3D (CyberMedic) on The 10mWT (10-m walking test )?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
the results for the 10mWT showed only significant improvements in the experimental group (11.38±3.0 to 10.12±2.47 seconds; p=0.01); whereas the control group did not show significant improvements.
|
[
"significantly increased"
] |
377
|
569
|
5256321
|
Compared to Biodex Balance System (Biodex Medical Systems, Shirley, NY, USA) what was the result of Spine Balance 3D (CyberMedic) on trunk strength (BPR score)?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
the results for the 10mWT showed only significant improvements in the experimental group (11.38±3.0 to 10.12±2.47 seconds; p=0.01); whereas the control group did not show significant improvements.
|
[
"significantly increased"
] |
378
|
574
|
4419460
|
Compared to control what was the result of The Child and Adolescent Structured Competencies Approach to Diabetes Education (CASCADE) is a structured educational group program, using psychological techniques, delivered primarily by diabetes nurses. on HbA1c at 12 or 24 months.?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Given that the trial found no evidence of benefits on venous HbA1c at 12 and 24 months and little evidence of benefits on secondary outcomes, the focus of this paper is to use the findings of the process evaluation to suggest how future structured education may be more effectively implemented.12
|
[
"no significant difference"
] |
379
|
576
|
4577567
|
Compared to free stride frequency what was the result of stride frequency manipulation on contact time?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
nversely, a decreased stride frequency (4.44%; p<0.0001) and internal work (7.09%; p<0.05) were found.
|
[
"significantly increased"
] |
380
|
577
|
4577567
|
Compared to free stride frequency what was the result of stride frequency manipulation on stride frequency?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
nversely, a decreased stride frequency (4.44%; p<0.0001) and internal work (7.09%; p<0.05) were found.
|
[
"significantly decreased"
] |
381
|
584
|
4819709
|
Compared to surgery what was the result of Ultrasound‐guided foam sclerotherapy on Lifting heavy objects without discomfort?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table
2
).
|
[
"significantly increased"
] |
382
|
588
|
4819709
|
Compared to surgery what was the result of Ultrasound‐guided foam sclerotherapy on Walking long distances (> 20 min)?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table
2
).
|
[
"significantly increased"
] |
383
|
594
|
4819709
|
Compared to surgery what was the result of Ultrasound‐guided foam sclerotherapy on Partial return to normal work/employment?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table
2
).
|
[
"significantly increased"
] |
384
|
596
|
4819709
|
Compared to surgery what was the result of Ultrasound‐guided foam sclerotherapy on Going out socially?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table
2
).
|
[
"significantly increased"
] |
385
|
597
|
4819709
|
Compared to surgery what was the result of Ultrasound‐guided foam sclerotherapy on Sporting activity or exercise?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table
2
).
|
[
"significantly increased"
] |
386
|
600
|
4819709
|
Compared to surgery what was the result of Endovenous laser ablation on Bending the legs without discomfort, Lifting heavy objects without discomfort, Moving from standing to sitting without discomfort, Standing still for a long time (> 15 min) without discomfort, Walking short distances (< 20 min) without discomfort, Walking long distances (> 20 min), Driving a car, Doing housework, Looking after children, Partial return to normal work/employment, Full return to normal work/employment, Going out socially, Sporting activity or exercise, ?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table
2
).
|
[
"significantly increased"
] |
387
|
606
|
5062194
|
Compared to equal volume of normal saline, 30 min before spinal anesthesia what was the result of intravenous dose of 0.035 mg/kg of midazolam on preoperative anxiety?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Mothers premedicated with midazolam showed a lower level of preoperative anxiety and a higher degree of postoperative satisfaction than the control group.
|
[
"significantly decreased"
] |
388
|
612
|
5577662
|
Compared to dose of 0.25 mg, 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated placebo (4:1 ratio) what was the result of receive a dose of 0.25 mg (1:1:1 ratio) and then allocated to active treatment (CCH) on global assessment of improvement?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
percentage changes in area were significantly greater with CCH 0.40 mg (−80.1%, P = 0.0002) and CCH 0.60 mg (−78.2%, P = 0.0003), but not CCH 0.25 mg (−58.3%, P = 0.079), versus placebo (−42.2%) at post-treatment Week 8.
|
[
"no significant difference"
] |
389
|
613
|
4794897
|
Compared to passive physical therapy what was the result of resistance training dyrung radiation therapy on pyridinoline?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Mean change values of PYD and CTX-I were significantly lower at 3 months after RT (p = 0.035 and p = 0.043)
|
[
"significantly decreased"
] |
390
|
486
|
2806484
|
Compared to Facility-based HIV-care strategy what was the result of Home-based HIV-care strategy on Mortality rates?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Rates of detection of plasma viral loads of more than 500 copies per mL after a 6-month visit were much the same in both groups.
|
[
"no significant difference"
] |
391
|
488
|
2806484
|
Compared to Facility-based HIV-care strategy what was the result of Home-based HIV-care strategy on Admission diagnoses?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Rates of detection of plasma viral loads of more than 500 copies per mL after a 6-month visit were much the same in both groups.
|
[
"no significant difference"
] |
392
|
489
|
2806484
|
Compared to Facility-based HIV-care strategy what was the result of Home-based HIV-care strategy on Increase in CD4-cell counts?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Rates of detection of plasma viral loads of more than 500 copies per mL after a 6-month visit were much the same in both groups.
|
[
"no significant difference"
] |
393
|
618
|
4139977
|
Compared to similar placebo, twice daily after a meal for 14 consecutive days what was the result of receive a probiotic compound containing seven bacteria species including Lactobacillus strains, Bifidobacterium strains and Streptococcus thermophiles on decrease in abdominal pain and distension severity?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
mprovement in bowel habit was observed in 33.3% of the probiotic and 36.5% of the placebo group (P = 0.910).
|
[
"no significant difference"
] |
394
|
490
|
2363351
|
Compared to Cisplatin and Cyclophosphamide what was the result of Cisplatin and Cyclophosphamide, plus subcutaneous IFN-γ on Progression-free survival after 3 years?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Three-year overall survival was 58% and 74% accordingly (n.s., median not yet reached).
|
[
"significantly increased"
] |
395
|
504
|
2376383
|
Compared to Placebo lozenge what was the result of PTA lozenge on Need of feeding tube?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Six patients (19%) in the placebo group (n=32) and two patients (6%) in the PTA group (n=33) needed nasogastric tube feeding during the evaluation period (P=0.08).
|
[
"no significant difference"
] |
396
|
506
|
2376383
|
Compared to Placebo lozenge what was the result of PTA lozenge on Candida sp. colonisation during the study?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
Six patients (19%) in the placebo group (n=32) and two patients (6%) in the PTA group (n=33) needed nasogastric tube feeding during the evaluation period (P=0.08).
|
[
"significantly decreased"
] |
397
|
508
|
1964758
|
Compared to BioModular® shoulder prosthesis what was the result of Initial Nottingham TSR design prosthesis on 8-year survivorship?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
The initial Nottingham TSR prostheses showed higher eight year survivorship than BioModular® prostheses in patients with OA (p < 0.01). Survivorship of the BioModular® prosthesis in patients with primary osteoarthritis was 70.9% and 64.3% at five and eight years respectively and for the initial Nottingham TSR these values were 84.5% and 80.4%
|
[
"significantly increased"
] |
398
|
513
|
2829413
|
Compared to Atorvastatin what was the result of Rosuvastatin on Levels of non-high-density lipoprotein cholesterol after 6 weeks of treatment?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
After 6 weeks of treatment, greater reductions in total cholesterol (- 35.94 ± 11.38 vs. - 30.07 ± 10.46%, p < 0.001), LDL-C (48.04 ± 14.45 vs. 39.52 ± 14.42%, p < 0.001), non-high-density lipoprotein cholesterol (- 42.93 ± 13.15 vs. - 35.52 ± 11.76%, p < 0.001), and apolipoprotein-B (- 38.7 ± 18.85 vs. - 32.57 ± 17.56%, p = 0.002) levels were observed in the rosuvastatin group as compared to the atorvastatin group.
|
[
"significantly decreased"
] |
399
|
516
|
2829413
|
Compared to Atorvastatin what was the result of Rosuvastatin on Changes in glucose and insulin levels?
|
multiple_choice
|
[
"significantly increased",
"no significant difference",
"significantly decreased"
] |
After 6 weeks of treatment, greater reductions in total cholesterol (- 35.94 ± 11.38 vs. - 30.07 ± 10.46%, p < 0.001), LDL-C (48.04 ± 14.45 vs. 39.52 ± 14.42%, p < 0.001), non-high-density lipoprotein cholesterol (- 42.93 ± 13.15 vs. - 35.52 ± 11.76%, p < 0.001), and apolipoprotein-B (- 38.7 ± 18.85 vs. - 32.57 ± 17.56%, p = 0.002) levels were observed in the rosuvastatin group as compared to the atorvastatin group.
|
[
"no significant difference"
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.